# BOSENTAN
> **ANDA213981** · Abbreviated New Drug Application (Generic) · Sponsor: ZYDUS PHARMS · Approved 2026-02-17
## Drug
- **FDA Application Number:** ANDA213981
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** BOSENTAN
- **Generic name:** BOSENTAN
- **Active ingredients:** BOSENTAN
- **Dosage form:** TABLET, FOR SUSPENSION
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** ZYDUS PHARMS
- **Manufacturer:** Zydus Pharmaceuticals USA Inc.
- **First approval:** 2026-02-17
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213981)
---
*AI Analytics · CC0 1.0*